Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Albany Molecular Res (AMRI)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 937,429
  • Shares Outstanding, K 43,120
  • Annual Sales, $ 570,450 K
  • Annual Income, $ -70,170 K
  • 36-Month Beta 1.17
  • Price/Sales 1.64
  • Price/Cash Flow 10.88
  • Price/Book 2.95
  • Price/Earnings ttm 24.43
  • Earnings Per Share ttm 0.57
  • Most Recent Earnings 0.13 on 05/09/17
  • Next Earnings Date 09/07/17
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
21.52 +1.02%
on 08/01/17
21.78 -0.18%
on 08/11/17
unch (unch)
since 07/31/17
3-Month
19.44 +11.83%
on 06/01/17
22.17 -1.94%
on 06/05/17
+2.28 (+11.72%)
since 05/31/17
52-Week
13.01 +67.10%
on 03/23/17
22.17 -1.94%
on 06/05/17
+7.14 (+48.90%)
since 08/26/16

Most Recent Stories

More News
Albany Molecular Has Returned 41.3% Since SmarTrend Recommendation (AMRI)

SmarTrend identified an Uptrend for Albany Molecular (NASDAQ:AMRI) on April 13th, 2017 at $15.39. In approximately 9 months, Albany Molecular has returned 41.31% as of today's recent price of $21.74.

AMRI : 21.74 (unch)
Uptrend Call Working As Albany Molecular Stock Rises 41.3% (AMRI)

SmarTrend identified an Uptrend for Albany Molecular (NASDAQ:AMRI) on April 13th, 2017 at $15.39. In approximately 9 months, Albany Molecular has returned 41.31% as of today's recent price of $21.74.

AMRI : 21.74 (unch)
Albany Molecular Up 41.3% Since SmarTrend Uptrend Call (AMRI)

SmarTrend identified an Uptrend for Albany Molecular (NASDAQ:AMRI) on April 13th, 2017 at $15.39. In approximately 8 months, Albany Molecular has returned 41.31% as of today's recent price of $21.74.

AMRI : 21.74 (unch)
Robbins Geller Rudman & Dowd LLP Files Class Action Suit against Albany Molecular Research, Inc.

Robbins Geller Rudman & Dowd LLP ("Robbins Geller") today announced that a class action has been commenced on behalf of holders of Albany Molecular Research, Inc. ("AMRI") (NASDAQ:AMRI)...

AMRI : 21.74 (unch)
Bourne Partners to Host 7th Annual Global Healthcare Executive Summit

The seventh annual Global Healthcare Executive Summit will take place this week in Charlotte, NC. Participants and guests representing global and specialty pharmaceutical, pharmaceutical...

AMRI : 21.74 (unch)
3ST Research Files Litigation Alleging Fraud and Conversion of Inventor's Intellectual Property Rights by Albany Molecular Research Inc. (AMRI)

3ST Research LLC, a company focused on the discovery, synthesis, and development of innovative abuse-resistant and abuse-deterrent opioids, announced the filing of litigation against Albany Molecular Research,...

AMRI : 21.74 (unch)
Technical Snapshots for These Biotech Stocks -- Alnylam Pharma, Alexion Pharma, Albany Molecular Research, and BioCryst Pharma

If you want a Stock Review on ALNY, ALXN, AMRI, or BCRX then come over to http://dailystocktracker.com/register/ and sign up for your free customized report today. Biotech stocks have performed well in...

ALNY : 129.07 (+0.80%)
BCRX : 5.62 (-0.71%)
AMRI : 21.74 (unch)
ALXN : 122.71 (+0.19%)
AMRI Announces Completion of Acquisition by The Carlyle Group and GTCR

Albany Molecular Research, Inc. (NASDAQ: AMRI), a global contract research, development and manufacturing organization working with the life sciences industry to improve patient outcomes and quality of...

CG : 25.30 (+2.43%)
AMRI : 21.74 (unch)
Shares of AMRI Up 41.2% Since Uptrend Call on Shares

SmarTrend identified an Uptrend for Albany Molecular (NASDAQ:AMRI) on April 13th, 2017 at $15.39. In approximately 5 months, Albany Molecular has returned 41.24% as of today's recent price of $21.73.

AMRI : 21.74 (unch)
Shares of AMRI Up 41.3% Since Uptrend Call on Shares

SmarTrend identified an Uptrend for Albany Molecular (NASDAQ:AMRI) on April 13th, 2017 at $15.39. In approximately 4 months, Albany Molecular has returned 41.31% as of today's recent price of $21.74.

AMRI : 21.74 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

See More

Business Summary

Albany Molecular Research is an integrated provider of drug discovery and development, chemistry research and manufacturing services. They offer services traditionally provided by chemistry divisions within pharmaceutical and biotechnology companies, including drug discovery, medicinal chemistry, chemical...

See More

Key Turning Points

2nd Resistance Point 21.77
1st Resistance Point 21.76
Last Price 21.74
1st Support Level 21.73
2nd Support Level 21.71

See More

52-Week High 22.17
Last Price 21.74
Fibonacci 61.8% 18.67
Fibonacci 50% 17.59
Fibonacci 38.2% 16.51
52-Week Low 13.01

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.